Anti-obese and anti-diabetic effects of a mixture of daidzin and glycitin on C57BL/6J mice fed with a high-fat diet

Bioscience, Biotechnology and Biochemistry

Volumn 79, Issue 1, 2015, Pages 117-123

  Zang, Yanqing ^a   Igarashi, Kiharu ^b   Yu, Changqing ^a  

^a HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

C57BL 6J mice; Daidzin and glycitin mixture; Diabetes; Obesity; Oxidative stress

Indexed keywords

ANTHROPOMETRY; BODY FLUIDS; FLAVONOIDS; MEDICAL PROBLEMS; MIXTURES; NUTRITION; OXIDATIVE STRESS; TISSUE;

ADIPOSE TISSUE; ANTI DIABETICS; C57BL/6J MICE; DAIDZIN; GLYCOSIDE FORMS; HIGH-FAT DIET; OBESITY; SERUM INSULIN;

MAMMALS;

MUS;

8-OXO-7-HYDRODEOXYGUANOSINE; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; DAIDZIN; DEOXYGUANOSINE; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUTATHIONE; GLYCITIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOFLAVONE DERIVATIVE;

ADIPOSE TISSUE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DIABETES MELLITUS; DRUG EFFECTS; FAT INTAKE; GLUCOSE BLOOD LEVEL; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; OBESITY; OXIDATIVE STRESS; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; DEOXYGUANOSINE; DIABETES MELLITUS; DIET, HIGH-FAT; DIETARY FATS; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; ISOFLAVONES; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; OXIDATIVE STRESS;

EID: 84924529240     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.955453     Document Type: Article

References (43)

1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531-543.
2. Orgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp. Biol. Med. 2008;233:1066-1080.
3. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat. Med. 2006;12:75-80.
4. Messina M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am. J. Clin. Nutr. 1999;70:574-575.
5. Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 1998;83:2223-2235.
6. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 2002;76:1191-1201.
7. Ishimi Y. Soybean isoflavones in bone health. Forum. Nutr. 2009;61:104-116.
8. Mori M, Aizawa T, Tokoro M, Miki T, Yamori Y. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in mid-dle-aged Japanese women. Clin. Exp. Pharmacol. Physiol. 2004;31:S39-S41.
9. Tutel'ian VA, Pavliuchkova MS, Pogozheva AV, Vorob'eva L, Derbeneva SA. The study of soy isoflavone metabolism in patients with cardiovascular diseases. Vopr. Pitan. 2002;71:20-22.
10. Kim MH, Bae YJ. Dietary isoflavone intake, urinary isoflavone level, and their relationship with metabolic syndrome diagnostic components in Korean postmenopausal women. Clin. Nutr. Res. 2013;2:59-66.
11. Klejdus B, Mikelová R, Petrlová J, Potesil D, Adam V, Stiborová M, Hodek P, Vacek J, Kizek R, Kubán V. Evaluation of isoflavone aglycon and glycoside distribution in soy plants and soybeans by fast column high-performance liquid chromatography coupled with a diode-array detector. J. Agric. Food Chem. 2005;53:5848-5852.
12. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 1994;42:1666-1673.
13. Choi I, Kim Y, Park Y, Seog H, Choi H. Anti-obesity activities of fermented soygerm isoflavones by Bifi dobacterium breve. BioFactors. 2007;29:105-112.
14. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000;130:1695-1699.
15. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isofl avone supplements. J. Nutr. 2001;131:1362-1375.
16. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 2003;77:1459-1465.
17. Kim DH, Jung HA, Park SJ, Kim JM, Lee S, Choi JS, Cheong JH, Ko KH, Ryu JH. The effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice. Arch. Pharm. Res. 2010;33:1685-1690.
18. Kim SH, Heo JH, Kim YS, Kang SS, Choi JS, Lee SM. Protective effect of daidzin against d-galactosamine and lipo-polysaccharide-induced hepatic failure in mice. Phytother. Res. 2009;23:701-706.
19. Meezan E, Meezan EM, Jones K, Moore R, Barnes S, Prasain JK. Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J. Agric. Food Chem. 2005;53:8760-8767.
20. Li XH, Zhang JC, Sui SF, Yang MS. Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts. Acta. Pharmacol. Sin. 2005;26:1081-1086.
21. Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol. Pharm. Bull. 2001;24:368-372.
22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957;226:497-509.
23. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 2006;281:16768-16776.
24. Kumar S, Korsey JA, Muesing RA, Porter JW. Comparative studies of the pigeon liver fatty acid synthetase complex and its subunits. J. Biol. Chem. 1970;245:4732-4744.
25. Carey EM, Dils R. Fatty acid biosynthesis. V. Purification and characterisation of fatty acid synthetase from lactating-rabbit mammary gland. Biochim. Biophys. Acta. Lipid Lipid Met. 1970;210:371-387.
26. Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006;79:1207-1213.
27. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J. Nutr. 1998;128:728-732.
28. Hsu CS, Chiu WC, Yeh SL. Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr. Res. 2003;23:67-75.
29. Crespillo A, Alonso M, Vida M, Pavón FJ, Serrano A, Rivera P, Romero-Zerbo Y, Fernández-Llebrez P, Martínez A, Pérez-Valero V, Bermúdez-Silva FJ, Suárez J, de Fonseca FR. Reduction of body weight liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br. J. Pharmacol. 2011;164:1899-1915.
30. Guo Y, Wu G, Su X, Yang H, Zhang J. Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutr. Res. 2009;29:656-663.
31. Harte RA, Kirk EA, Rosenfeld ME, LeBoeuf RC. Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm. Metab. Res. 1999;31:570-575.
32. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-643.
33. Zhang Y, Na X, Li L, Zhao X, Cui H. Isoflavone reduces body weight by decreasing food intake in ovariectomized rats. Ann. Nutr. Metab. 2009;54:163-170.
34. Hamden K, Jaouadi B, Carreau S, Aouidet A, Elfeki A. Therapeutic effects of soy isoflavones on alpha-amylase activity, insulin deficiency, liver-kidney function and metabolic disorders in diabetic rats. Nat. Prod. Res. 2011;25:244-255.
35. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci. 2006;79:1578-1584.
36. Sosic-Jurjevic B, Filipovic B, Ajdzanovic V, Brkic D, Ristic N, Stojanoski MM, Nestorovic N, Trifunovic S, Sekulic M. Subcutaneously administrated genistein and daidzein decrease serum cholesterol and increase triglyceride levels in male middle-aged rats. Exp. Biol. Med. 2007;232:1222-1227.
37. Zimmermann C, Cederroth CR, Bourgoin L, Foti M, Nef S. Prevention of diabetes in db/db mice by dietary soy is independent of isoflavone levels. Endocrinology. 2012;153:5200-5211.
38. Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 2008;24:74-81.
39. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997;389:610-614.
40. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 2002;60:1-14.
41. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1995;1:1155-1161.
42. Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 2004;134:2499-2503.
43. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 1998;356:133-141.